{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:48:36Z","timestamp":1791301716744,"version":"4.1.0"},"reference-count":47,"publisher":"SAGE Publications","issue":"5-6","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Human Gene Therapy"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>\n                    Patients with central nervous system (CNS) lymphomas have a poor prognosis. Chimeric antigen receptor-modified (CAR) T cells have shown remarkable efficacy for B-cell non-Hodgkin's lymphoma. However, few studies have reported the effects of CAR T cells in the treatment of CNS lymphoma, and the duration of remission is short. In this study, seven CNS lymphoma patients (six patients with secondary CNS lymphomas and one patient with primary CNS lymphoma) were treated with CD19 or CD20 CAR T cell therapy, and the clinical efficacy and toxicity profiles were evaluated. All patients responded to CAR T cell therapy. Four patients achieved complete remission (CR), while three demonstrated partial remission. We also found that either CD19 or CD20 CAR T cells could be detected in the cerebrospinal fluid of four patients. The median progression-free survival and median overall survival were not assessed. The median duration of CR was 22.4 months. Five patients (5\/7) in this cohort received combination therapy (bridging with autologous hematopoietic stem cell transplantation and programmed death-1 inhibitor for maintenance treatment) and three (3\/7) received CAR T cell therapy as soon as possible after the relapse of CNS lymphoma. This could help explain why these patients achieved long-term remission. After a median follow-up of 10.4 months, three patients demonstrated disease progression, and the antigen loss of CD20 was confirmed as the reason for relapse in one patient. The results of this study suggest that CD19 or CD20 CAR T cells are effective against CNS lymphoma. This research was registered at\n                    <jats:uri xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.chictr.org.cn\">http:\/\/www.chictr.org.cn<\/jats:uri>\n                    (No. ChiCTR2000036350).\n                  <\/jats:p>","DOI":"10.1089\/hum.2021.249","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T07:28:22Z","timestamp":1644650902000},"page":"318-329","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":24,"title":["CD19 or CD20 CAR T Cell Therapy Demonstrates Durable Antitumor Efficacy in Patients with Central Nervous System Lymphoma"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2661-7183","authenticated-orcid":false,"given":"Rui","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Kang","sequence":"additional","affiliation":[{"name":"Shanghai Unicar-Therapy Bio-Medicine Technology Co., Ltd, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, The Third Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Third Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Tan","sequence":"additional","affiliation":[{"name":"Shanghai Unicar-Therapy Bio-Medicine Technology Co., Ltd, Shanghai, China"},{"name":"Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Xu","sequence":"additional","affiliation":[{"name":"Shanghai Unicar-Therapy Bio-Medicine Technology Co., Ltd, Shanghai, China"},{"name":"Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Unicar-Therapy Bio-Medicine Technology Co., Ltd, Shanghai, China"},{"name":"Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[{"name":"Shanghai Unicar-Therapy Bio-Medicine Technology Co., Ltd, Shanghai, China"},{"name":"Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-182253"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh013"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.8021"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.01.073"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl327"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr440"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30747-2"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.5533"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.07.006"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.060434"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.565"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30864-7"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2016.10.020"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1704610"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-01099-4"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020004106"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01306"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001694"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018883421"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-738245"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.4161\/onci.26286"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.664421"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01100-2"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.701"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05816-y"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.148"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00523-2"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134449"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2025"},{"key":"e_1_3_6_36_2","first-page":"372","article-title":"Mechanisms of resistance to CAR T cell therapy","volume":"16","author":"Shah NN","year":"2019","unstructured":"Shah NN, , Fry TJ. Mechanisms of resistance to CAR T cell therapy. Nat Rev Clin Oncol, 2019; 16:372\u2013385.","journal-title":"Nat Rev Clin Oncol"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3259"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2017.126"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1081-3"},{"key":"e_1_3_6_40_2","first-page":"1632","article-title":"Optimized tandem CD19\/CD20 CAR-engineered T cells in refractory\/relapsed B-cell lymphoma","volume":"136","author":"Tong C","year":"2020","unstructured":"Tong C, , Zhang Y, , Liu Y, et al. Optimized tandem CD19\/CD20 CAR-engineered T cells in refractory\/relapsed B-cell lymphoma. Blood, 2020; 136:1632\u20131644.","journal-title":"Blood"},{"key":"e_1_3_6_41_2","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2019.01.10"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16263"},{"key":"e_1_3_6_43_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003001"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002394"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02103"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001837"},{"key":"e_1_3_6_47_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.706087"},{"key":"e_1_3_6_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12529"}],"container-title":["Human Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/hum.2021.249","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/hum.2021.249","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/hum.2021.249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:56:27Z","timestamp":1777449387000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/hum.2021.249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":47,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1089\/hum.2021.249"],"URL":"https:\/\/doi.org\/10.1089\/hum.2021.249","relation":{},"ISSN":["1043-0342","1557-7422"],"issn-type":[{"value":"1043-0342","type":"print"},{"value":"1557-7422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}